Search results
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 7 days agoThe consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher than the current price. Novavax has become a safer...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 7 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 5 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 7 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Analysis | Court rejects abortion pill challenge, but what happens next?
Washington Post· 7 days agoWhat do you think is next in the fight over medication abortion? Today’s edition: Senate Republicans...
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
InvestorPlace· 2 days agoIt was not long ago that Novavax (NASDAQ:NVAX) was among the stocks with high short interest. In the...
